Hyphens Pharma Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, launched its Ceradan® Advanced Hand Balm, the latest addition to its Ceradan® line for […]
Tag: Healthcare
Hyphens Pharma 1H2024 net profit jumps 66.7% to S$5.9 million
Hyphens Pharma Limited reported 1H2024 revenue grew by 33.4% to S$99.6 million in 1H2023 with all three business segments contributing to the growth. Revenue from […]
Hyphens Pharma to bring relief to Shingles sufferers in ASEAN with licensing of Amenalief®
Singapore’s leading specialty pharmaceutical and consumer healthcare group, Hyphens Pharma International Limited’s subsidiary, Hyphens Pharma Pte. Ltd., has entered into an exclusive license, development and […]
Hyphens Pharma 3Q2023 net profit drops to S$4 million due to challenging macro environment and record 3Q2022 results
Hyphens Pharma Limited has released its quarterly business update for 3Q2023 and 9M2023. 3Q2023 compared to 3Q2022 Revenue in 3Q2023 remained constant at S$42.8 million […]
Hyphens Pharma acquires Ardence Pharma in Malaysia
Hyphens Pharma Limited has acquired Ardence Pharma Sdn Bhd, a boutique pharmaceutical company specializing in aesthetic medicine and an existing associate company of Hyphens Group […]
Vicplas announces new manufacturing facility in Mexico
Vicplas International Ltd’s medical devices segment (“MDS” or “Forefront Medical”) has signed a lease with Parques American Industries, S.A. De C.V., for a new 68,000 […]
Vicplas International posts FY2023 revenue of S$129.2 million with a profit after tax of S$4.2 million
Vicplas International announced its FY2023 results, with revenue decreasing slightly by 1.2% to S$129.2 million from S$130.8 million in FY2022 due to lower revenue from […]
Hyphens Pharma sees soft 1Q2023 due to end of Biosensors distributorship and Vietnam shipment delays
1Q2023 Financial Review Hyphens Pharma Limited’s revenue fell by 15.2% or S$6.0 million from S$39.2 million in 1Q2022 to S$33.2 million in 1Q2023. This was […]
Vicplas FY2022 revenue grew 14.8% to S$130.8 million with a net profit of S$8.8 million
Vicplas International FY2022 revenue for its financial year ended 31 July 2022, increased 14.8% to S$130.8 million from S$113.9 million in FY2021. Profit after tax […]
Vicplas FY2021 net profit rose 112.5% to S$10.4 million with medical devices driving growth
Vicplas International has achieved a profit after tax of S$10.4 million for FY2021 ended 31 July 2021, an increase of 112.5% from S$4.9 million for […]